Birdwatch Archive

Birdwatch Note

2024-11-21 14:27:09 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Fehlender Kontext: Zitierte Studie verfolgt primär wirtschaftlichen Ansatz, indem sie untersucht, ab welchem Risiko für Herz-Kreislauf-Erkrankungen der Einsatz von Statinen kostensparend für das Gesundheitssystem ist. Determining Cost-Saving Risk Thresholds for Statin Use: https://www.medrxiv.org/content/10.1101/2024.08.14.24311999v1 m

Written by 54DF1AA265AE74216EB37ACF289A57669AADE6ECBC771DF0D4DFF57BE46EDEFF
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1859593322550964362

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1859604466040799407
  • noteId - 1859604466040799407
  • participantId -
  • noteAuthorParticipantId - 54DF1AA265AE74216EB37ACF289A57669AADE6ECBC771DF0D4DFF57BE46EDEFF Participant Details
  • createdAtMillis - 1732199229141
  • tweetId - 1859593322550964362
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Fehlender Kontext: Zitierte Studie verfolgt primär wirtschaftlichen Ansatz, indem sie untersucht, ab welchem Risiko für Herz-Kreislauf-Erkrankungen der Einsatz von Statinen kostensparend für das Gesundheitssystem ist. Determining Cost-Saving Risk Thresholds for Statin Use: https://www.medrxiv.org/content/10.1101/2024.08.14.24311999v1 m

Note Ratings

rated at rated by
2024-11-21 14:14:41 -0600 Rating Details
2024-11-21 08:36:47 -0600 Rating Details